Board Meeting Announcement for Kabra Drugs Ltd - Dec 4, 2024

Inter alia to consider and approve the following matters: 1. To consider and approve proposal of fund raising by issue of equity shares or any other permitted mode, through Preferential Allotment/Private Placement / Convertible warrants basis to the Promoter /Non-Promoter / Public Category of investors in accordance with the provision of the Companies Act, 2013 and SEBI (Issue of Capital and Disclosure Requirements Regulation, 2018, as amended, subject to regulatory or statutory approvals as may be required including the approval of the shareholders of the Company. 2. Increase in Authorised Share Capital of the company from 2,00,00,000 shares to 3,00,00,000 of Rs. 10 each. 3. To Consider shifting of Registered office of the company from Shop 208, Swadesh Bhavan, 2 Press Complex, AB Road, Indore, Madhya Pradesh 452011to No.3, 1st Floor, Swaminathan Street, West Mambalam, Chennai -